You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康聖環球(09960.HK):康聖環球武漢擬收購北京博富瑞基因診斷技術約11.38%股權
格隆匯 07-15 21:25

格隆匯7月15日丨康聖環球(09960.HK)公吿,於2024年6月30日,康聖環球(武漢)醫學特檢技術有限公司(康聖環球武漢)(一家基於可變權益實體架構已將其財務業績作為公司附屬公司的方式合併及入賬處理的中國綜合實體與三名個人(轉讓人)及若干其他締約方訂立一份股權轉讓協議及一份股權轉讓補充協議,據此,康聖環球武漢同意附條件收購轉讓人持有的北京博富瑞基因診斷技術有限公司(目標公司)合共約11.38%的股權,總代價合計為人民幣3187.6萬元。

於收購事項完成後,目標公司將不會成為康聖環球武漢的附屬公司,其財務業績亦不會合並至集團的綜合財務報表。

目標公司為一家於2002年2月9日根據中國法律成立的有限公司,其主要從事移植醫學領域的分子免疫指標特檢服務、醫療器械銷售業務及科研服務。目標公司的附屬公司包括廣州博富瑞醫學檢驗有限公司、杭州博富瑞醫學檢驗實驗室有限公司及北京博富瑞醫學檢驗實驗室有限公司。截至本公吿日期,目標公司由北京博富瑞科技有限公司持有約33.54%股權,及由劉向東先生持有約22.72%股權;北京博富瑞科技有限公司則由劉向東先生持有約89.49%股權。

董事會認為,目標公司是國內移植特檢和專業服務領域的龍頭企業,具備專業技術領先,持續發展能力穩定特點,收購事項將對公司有利,因為其可進一步完善集團全面、系統、先進專科特檢戰略體系;通過產業協同,提高集團核心檢測技術在移植市場的滲透率、影響力以及客户服務效能。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account